Schick Technologies has been delisted from the Nasdaq stock exchange, the company has reported. On Sept. 15, Schick received notice from the Nasdaq Listing Qualifications Panel that as of close of business, Schick’s common stock would no longer be
Schick Technologies has been delisted from the Nasdaq stock exchange, the company has reported. On Sept. 15, Schick received notice from the Nasdaq Listing Qualifications Panel that as of close of business, Schicks common stock would no longer be traded on the exchange. The panel attributed its decision to Schicks inability to file its 10-K for fiscal 1999 (end-March) on time, as well as factors discussed in Schicks 8-K, filed on Sept. 2.
Schick will request a review of the panels decision within the 15-day limit required by Nasdaqs marketplace rules, and plans to file its 10-K and its 10-Q for the quarter ended June 30 as soon as the firms new accountants, Grant Thornton, complete their audit of Schicks financial statements. Schicks former accounting firm, PricewaterhouseCoopers, resigned as the companys independent accountants on Aug. 25. Schick will seek relisting on the exchange, or apply for listing on another exchange, once its filings are current with the Securities and Exchange Commission, according to the Long Island City, NY-based company.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.